DNMT3A and diffuse large B-cell lymphoma: Studies have revealed that in DLBCL, PA can upregulate the expression levels of MiR‐429 and FOXO1 while downregulating the expression of DNMT3A by modulating the miR‐429/DNMT3A axis.